HOFJF yields 1.45% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 7
Combined, HOFJF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HOFJF + JNJ for your $10,000?
House Foods Group Inc. engages in the manufacture, sale, import, and export of spices, seasonings, processed foods, and commercial use food products in Japan and internationally. It operates through Spice/Seasoning/Processed Food Business, Health Food Business, Restaurant Business, International Food Business, and Other Food Related Business segments. The company offers curry, stew, starch, processed meat, retort pouched food products, etc.; condiments, such as curry roux products; soy-bean products, prepared dishes, baked breads, dessert products, and beverages; health food products through mail-order; and frozen vegetables, mustard essential oils, processed foods, etc. It also conducts agricultural management; processes and sells agricultural products; provides safety and sanitation analysis for food products; and operates and transport and warehouses. In addition, the company is involved in the restaurant operations guidance and trading services; and marketing of vegetables. It operates 1,259 restaurants in Japan and 202 restaurants internationally under the Ichibanya name. The company was formerly known as House Foods Corp and changed its name to House Foods Group Inc. in 2013. House Foods Group Inc. was founded in 1913 and is headquartered in Tokyo, Japan.
Full HOFJF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.